Australia markets close in 3 hours 37 minutes

Tasly Pharmaceutical Group Co., Ltd (600535.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
15.85-0.06 (-0.38%)
As of 10:20AM CST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
8,637,978
8,674,014
8,637,429
7,951,957
13,576,115
Cost of revenue
2,833,613
2,880,103
3,120,919
2,677,531
8,109,105
Gross profit
5,804,365
5,793,911
5,516,510
5,274,426
5,467,010
Operating expenses
Research development
951,087
917,269
845,344
579,527
689,331
Selling general and administrative
3,076,410
3,066,273
3,002,935
3,071,329
2,897,454
Total operating expenses
4,326,296
4,289,106
4,150,776
3,962,223
3,933,012
Operating income or loss
1,478,069
1,504,805
1,365,734
1,312,202
1,533,997
Interest expense
81,534
82,524
64,411
77,391
286,690
Income before tax
1,209,545
1,221,097
-167,632
2,723,540
1,457,053
Income tax expense
161,051
204,457
180,823
315,925
367,195
Income from continuing operations
1,048,494
1,016,640
-348,455
2,407,616
1,089,857
Net income
1,101,698
1,071,072
-264,238
2,358,865
1,125,891
Net income available to common shareholders
1,101,698
1,071,072
-264,238
2,358,865
1,125,891
Basic EPS
0.75
0.72
-0.18
1.57
0.75
Diluted EPS
0.75
0.72
-0.18
1.57
0.75
Basic average shares
1,509,035
1,487,600
1,467,991
1,502,462
1,501,188
Diluted average shares
1,509,035
1,487,600
1,467,991
1,502,462
1,501,188